HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Vitreous Biopsy

Vitreous Biopsy

Vitreous biopsy, a minimally invasive procedure, is gaining traction in cancer research for its potential in diagnosing ocular malignancies. By extracting a small sample of the vitreous humor—the gel-like substance within the eye—researchers can identify cancerous cells or genetic material shed from tumors in the eye. This technique offers several advantages, including its low risk, ability to provide real-time molecular information, and its potential to guide personalized treatment strategies. Moreover, vitreous biopsy presents an opportunity for early cancer detection, crucial for improving patient outcomes. As technology advances, refining the sensitivity and specificity of vitreous biopsy could revolutionize ocular oncology, offering new insights into tumor biology and facilitating targeted therapies for eye cancers.

Committee Members
Committee Member - Michael Thompson

Michael Thompson

University of Toronto, Canada
Committee Member - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp